SEED group leader, Dr. Dr. Sebastian Balbach receives DFG funding of 240,000 Euros for 2 years

Dr. Dr. Sebastian Balbach (Photo: MFM/FZ - E. Deiters-Keul)

The IZKF SEED project leader, Dr. Dr. Sebastian Balbach is a biologist and resident at the Clinic for Pediatric and Adolescent Medicine – Pediatric Hematology and Oncology. Dr. Sebastian Balbach researches new, targeted therapies against rhabdomyosarcoma, a malignant tumor of muscle tissue that often occurs in children. Dr Balbach and his team found a specific gene in the tumor cells that appears to be particularly important. Blocking this gene kills the cancer cells. By suppressing the production of mRNA, Sebastian Balbach is developing a targeted therapy for rhabdomyosarcoma. The German Research Foundation (DFG) is funding the project with 240.000 EUROS over the next two years.